Author:
Allam Essmat A. H.,Sabra Mahmoud S.
Publisher
Springer Science and Business Media LLC
Reference91 articles.
1. Zhu C, Wang D-Q, Zi H, Huang Q, Gu J-M, Li L-Y et al (2021) Epidemiological trends of urinary tract infections, urolithiasis and benign prostatic hyperplasia in 203 countries and territories from 1990 to 2019. Mil Med Res 8:1–12
2. Sigurjonsdottir VK, Runolfsdottir HL, Indridason OS, Palsson R, Edvardsson VO (2015) Impact of nephrolithiasis on kidney function. BMC Nephrol 16:149. https://doi.org/10.1186/s12882-015-0126-1
3. Zeng G, Zhu W, Robertson WG, Penniston KL, Smith D, Pozdzik A et al (2022) International Alliance of Urolithiasis (IAU) guidelines on the metabolic evaluation and medical management of urolithiasis. Urolithiasis 51:4
4. Zumstein V, Betschart P, Abt D, Schmid H-P, Panje CM, Putora PM (2018) Surgical management of urolithiasis—a systematic analysis of available guidelines. BMC Urol 18:25. https://doi.org/10.1186/s12894-018-0332-9
5. Abu Zarin M, Tan JS, Murugan P, Ahmad R (2020) Investigation of potential anti-urolithiatic activity from different types of Musa pseudo-stem extracts in inhibition of calcium oxalate crystallization. BMC Complement Med Therap 20:1–12